These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17194487)

  • 1. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
    Chang LL; Cheng PN; Chen JS; Young KC
    Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.
    Kronenberger B; Herrmann E; Hofmann WP; Wedemeyer H; Sester M; Mihm U; Ghaliai T; Zeuzem S; Sarrazin C
    J Leukoc Biol; 2006 Aug; 80(2):298-308. PubMed ID: 16735696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
    Kronenberger B; Rüster B; Elez R; Weber S; Piiper A; Lee JH; Roth WK; Zeuzem S
    Hepatology; 2001 Jun; 33(6):1518-26. PubMed ID: 11391542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
    D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients.
    Micheloud D; González-Nicolás J; Berenguer J; Lorente R; Miralles P; López JC; Cosín J; Catalán P; Muñoz-Fernández M; Resino S
    HIV Med; 2010 Mar; 11(3):161-9. PubMed ID: 19780859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
    Hofmann WP; Sarrazin C; Kronenberger B; Schönberger B; Bruch K; Zeuzem S
    J Infect Dis; 2003 Mar; 187(6):982-7. PubMed ID: 12660945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
    Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of amantadine on CD81 expression on lymphocytes in chronic hepatitis C.
    Welker MW; von Wagner M; Ochs D; Zimmer V; Hofmann WP; Piiper A; Hartmann RW; Herrmann E; Zeuzem S; Kronenberger B
    Dig Liver Dis; 2010 Oct; 42(10):735-40. PubMed ID: 20457015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
    Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
    J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.
    Carrera G; Paternain JL; Carrere N; Folch J; Courtade-Saïdi M; Orfila C; Vinel JP; Alric L; Pipy B
    Am J Gastroenterol; 2003 May; 98(5):1142-9. PubMed ID: 12809840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1 and Th2 cytokines are elevated in HCV-infected SVR(-) patients treated with interferon-alpha.
    Wan L; Kung YJ; Lin YJ; Liao CC; Sheu JJ; Tsai Y; Lai HC; Peng CY; Tsai FJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):855-60. PubMed ID: 19118522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
    Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
    Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy.
    Schott E; Witt H; Neumann K; Bergk A; Halangk J; Weich V; Müller T; Puhl G; Wiedenmann B; Berg T
    J Viral Hepat; 2008 Jan; 15(1):71-8. PubMed ID: 18088248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
    Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
    J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
    Kronenberger B; Sarrazin C; Hofmann WP; von Wagner M; Herrmann E; Welsch C; Elez R; Rüster B; Piiper A; Zeuzem S
    J Viral Hepat; 2004 Jul; 11(4):310-8. PubMed ID: 15230853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
    Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
    J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.